Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schwartz

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Journal of the Society for Gynecologic Investigation|May 4, 2004
Apoptosis-based evaluation of chemosensitivity in ovarian cancer patientsMaryann B Flick, David O'Malley, Thomas Rutherford, et al.
Gynecologic Oncology Reports|January 10, 2022
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sitesJessie Y Li, Levent Mutlu, Joan Tymon-Rosario, et al.
Cancer|March 27, 2009
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxelDan Su, Stephanie M Smith, Mario Preti, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironmentWei Ma, Jing Ma, Jie Xu, et al.
The Journal of Biological Chemistry|January 29, 2011
Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injuryMarion Hölscher, Monique Silter, Sabine Krull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapyStephanie Smith, Dan Su, Irene A Rigault de la Longrais, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Macrophage migration inhibitory factor expression in ovarian cancerRinki Agarwal, Dong Hee Whang, Ayesha B Alvero, et al.
The Yale Journal of Biology and Medicine|October 18, 2007
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancerDan-Arin Silasi, Ayesha B Alvero, Jessica Illuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinomaTanja Pejovic, Daniela Ladner, Marilyn Intengan, et al.
Cureus|April 27, 2022
Development of a Computer-Tailored Intervention/Decision Aid To Increase Colorectal Cancer Screening in Health SystemsHala Fatima, Maryiam Wajid, Connie Krier, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Journal of the Society for Gynecologic Investigation|May 4, 2004
Apoptosis-based evaluation of chemosensitivity in ovarian cancer patientsMaryann B Flick, David O'Malley, Thomas Rutherford, et al.
Gynecologic Oncology Reports|January 10, 2022
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sitesJessie Y Li, Levent Mutlu, Joan Tymon-Rosario, et al.
Cancer|March 27, 2009
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxelDan Su, Stephanie M Smith, Mario Preti, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironmentWei Ma, Jing Ma, Jie Xu, et al.
The Journal of Biological Chemistry|January 29, 2011
Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injuryMarion Hölscher, Monique Silter, Sabine Krull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapyStephanie Smith, Dan Su, Irene A Rigault de la Longrais, et al.
American Journal of Obstetrics and Gynecology|April 4, 2007
Macrophage migration inhibitory factor expression in ovarian cancerRinki Agarwal, Dong Hee Whang, Ayesha B Alvero, et al.
The Yale Journal of Biology and Medicine|October 18, 2007
MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancerDan-Arin Silasi, Ayesha B Alvero, Jessica Illuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2004
Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinomaTanja Pejovic, Daniela Ladner, Marilyn Intengan, et al.
Cureus|April 27, 2022
Development of a Computer-Tailored Intervention/Decision Aid To Increase Colorectal Cancer Screening in Health SystemsHala Fatima, Maryiam Wajid, Connie Krier, et al.
Pageof 7